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Abstract
The mitochondrial pH gradient across the inner-membrane is stabilised by buffering of the matrix. A low-molecular
mass buffer compound has to be localised in the matrix to maintain its alkaline pH value. Taurine is found ubiqui-
tously in animal cells with concentrations in the millimolar range and its pKa value is determined to 9.0 (25°C) and
8.6 (37°C), respectively. Localisation of such a low-molecular buffer in the mitochondrial matrix, transforms the
matrix into a biochemical reaction chamber for the important matrix-localised enzyme systems. Three acyl-CoA
dehydrogenase enzymes, which are pivotal for beta-oxidation of fatty acids, are demonstrated to have optimal
activity in a taurine buffer. By application of the model presented, taurine depletion caused by hyperglycemia
could provide a link between mitochondrial dysfunction and diabetes.
Background
Intracellular localisation of taurine
Taurine has recently been proposed to have an impor-
tant role in mitochondria in animal cells [1]. The
hypothesis is based on the fact that taurine is found in
very high concentrations in oxidative tissue, but in
lower concentrations in glycolytic tissue. The studies on
the contents of porcine muscle tissue determined that
taurine is found in high concentrations of 15-20 µmol/g
in the oxidative porcine muscle tissue, but only 1-3
µmol/g in the low-oxidative glycolytic muscles [1,3].
Studies on muscles from horse and human have demon-
strated that taurine is preferentially localised in oxidative
muscle fibres [4,5]. Across the cell membrane, a Na+-
taurine symporter maintains a taurine gradient, whereas
an osmo-sensitive channel regulates efflux of taurine
(for reviews on taurine uptake, volume sensitive release,
transporter systems and the involvement in osmoregula-
tion, see [6,7]). If taurine is associated with mitochon-
dria and a taurine transporter system exist across the
mitochondrial membranes, the higher taurine content
found in oxidative tissue can easily be explained by a
simple two-compartment model due to the fact that
oxidative tissue is more mitochondria-rich than glycoly-
tic tissue [1].
A study [8] on intracellular compartmentation applied
analytical NMR spectroscopy for studying the low-mole-
cular composition of isolated mitochondria compared to
intact rat heart tissue. When comparing the intensities
in the shown spectra in [8] of intact tissue, tissue
extract, isolated intact mitochondria and mitochondria
extract, it is evident that the only low-molecular com-
pounds found in substantial concentrations inside the
mitochondria are taurine and lipids. However, as sample
preparation retaining the low-molecular fraction is very
difficult in such studies, the results can only be evalu-
ated qualitatively, but taurine seems to have an impor-
tant role in mitochondria. Further support is obtained
from the results of several immunocytochemical locali-
zation experiments of taurine [9,10]. These studies have
clearly demonstrated a preferential localization of taur-
ine in the mitochondria compared with the cellular
cytosol through immunogold labelling of taurine and
application of electron microscopy.
A very recent report [11] on the taurine concentration
found about 70 nmol/(mg protein) in mitochondria iso-
lated from rat heart. Mitochondrial protein mass has
been reported to represent about 30% of the total mito-
chondrial mass [12], so 70 nmol/(mg protein) corre-
sponds to about 20-30 µmol/g wet tissue, and in the
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about 30-40 mmol/l.
Taurine has also been demonstrated to be a constitu-
ent of modified uridine residues in mitochondrial
tRNA [13]. It was shown that the nucleotides were
synthesized in-vitro in the mitochondria when supply-
ing taurine to the cell incubation medium. Further-
more, the study reported that taurine was taken up by
isolated mitochondria, although the mitochondrial
taurine transporter has not yet been identified. As
mitochondrial tRNA is synthesized in the mitochon-
drial matrix, subsequent processing and modification is
expected to be performed inside the mitochondrial
matrix as well, thus demonstrating the matrix exis-
tence of taurine. The study also showed that taurine-
modified uridines were lacking in mutated mitochon-
drial tRNAs associated with mitochondrial diseases.
Due to the role in mitochondrial tRNA, taurine has
been suggested an important role directly in the trans-
lation and expression of the mitochondrial respiratory
proteins. This line of argument can be found presented
elsewhere [14].
Mitochondrial oxidation and the chemiosmotic theory
The chemiosmotic theory proposed by Peter Mitchell in
1961 [15] and refined during the 1960s is today consid-
ered as the theoretical basis for understanding of the
oxidative processes and ATP production in the mito-
chondria [16,17].
T h ec h e m i o s m o t i ct h e o r yc a nb ef o r m u l a t e da sf o l -
lows: ATP production by ATP synthase is driven by a
proton flux across the mitochondrial inner-membrane.
The the chemical potential Δμ for the proton flux
across the membrane, can be expressed as a sum of two
contributions:
Δμ =F ΔΨ – 2.303 RT ΔpH
The term FΔΨ is the electrical membrane potential
across the inner-membrane multiplied by the Faraday
constant F. The contribution 2.303 RT ΔpH represents
the free energy difference associated with the existence
of a pH gradient across the membrane.
The amount of protons forming the proton gradient
can be considered as temporary proton reservoir to
dampen transients and fluctuations in the subsequent
proton flux. Actually, the use of traditional water towers
to create a stable water supply could be compared with
the role of the proton gradient.
The existence of the pH gradient was demonstrated
experimentally in the late 1960s and 1970s by different
techniques like indicator compounds or microelectrodes
[18]. Later, application of fluorescent protein techniques
on mammalian cells has confirmed the existence of the
pH gradient by reporting a mildly alkaline pH value for
the mitochondrial matrix of 7.9-8.4 and for the cytosol
7.2-7.4 [19,20].
Buffering capacity of the mitochondria
The mitochondrial pH buffering capacities for outer and
inner compartments stabilise the pH gradient. However,
except for the original studies by Mitchell and Moyle
[16,17,21], few studies or presentations, if any, can be
found on the relationship between the pH gradient and
the mitochondrial buffering capacities.
Mitchell and Moyle determined the pH buffering
capacities of rat liver mitochondria as a function of pH
[21]. In the pH range from 7.5-8.5, the total buffering
capacity was determined to be about 40-50 µmol H
+/g
mitochondrial protein, which was divided into the con-
tributions of outer mitochondria buffering capacity
(30-40 µmol H
+/g mitochondrial protein) and inner
mitochondrial buffering capacity (10-20 µmol H
+/g
mitochondrial protein). Mitochondrial protein mass has
been reported to represent about 30% of the total mito-
chondrial mass [12].
However, examination of the tissue preparation
reported in the classical study by Mitchell and Moyle
(see Figure 6 and 7 in [21]) reveal that any water-soluble
low-molecular compounds localised inside the mito-
chondria is likely to have been washed away before per-
forming the pH titrations. Nothing is mentioned about
low-molecular compounds contributing to the pH buf-
f e r i n g ,i . e .a n ym i t o c h o n d r i a l-localised low-molecular
compound like taurine in high concentrations has prob-
ably not contributed to the determined buffering
capacities.
In addition, it is relevant to compare with some classi-
cal studies on fish skeletal muscles [23] or on mamma-
lian skeletal muscle [24], as these studies on tissue
fractionation with subsequent titrations found that
about two thirds of the buffering capacity, even at pH
8.0, is due to low-molecular mass compounds.
The well-known physiological buffer systems, carbon
dioxide / hydrogen carbonate and hydrogen phosphate /
dihydrogen phosphate, are possibly the most obvious
low-molecular candidates for mitochondrial buffering.
However, as seen from the pKa values in Figure 1, these
buffer systems can provide acceptable buffering in the
compartment controlling the low pH of the pH gradient
(pH 7.0-7.5), whereas their buffering capacity seems
inadequate in a mildly alkaline compartment like the
mitochondrial matrix (pH 7.9-8.5).
Biological buffers
In porcine muscle tissue, the histidine-related com-
pounds carnosine and anserine identified as buffers can
be found in the concentration range of 10-15 µmol/g in
muscles with low oxidative capacity and only 1-3 µmol/g
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sidered as glycolytic buffers and thus to be found in the
cytosol. In addition carnosine and anserine will not be
able to provide sufficient buffering capacity at pH 8.0 and
above with pKa values about 7.0 (see Figure 1).
Considering low-molecular mass components, only a
limited number of compounds are traditionally consid-
ered as physiological buffers. Besides, only a limited
number of synthetic buffers are traditionally used in cell
biology and biochemistry. An overview of such synthetic
biochemical research and physiological buffers (includ-
ing taurine) is presented in Figure 1. In spite of the
non-physiological origin of many of the buffers, they
have been used in many biochemical and cell biological
studies with subsequent physiological conclusions. It
should be noticed that HEPES and PIPES contain the
amino ethane sulphonate structural element of taurine.
In many lists of buffers to be found elsewhere [28,29] or
from laboratory chemical vendors, no or very few com-
pounds with a pKa of about 8-9 can be found. However,
in Figure 1 we have included Taurine, the commonly
used Tris and Glycylglycine, as well as the rarely used
Tricine, Bicine and TAPS.
Results and discussion
Buffering properties of taurine
T h es u l p h o n a t eg r o u pi nt a u r i n ew i t hap K av a l u e
about 1.5 (at 25°C) is negatively charged at all physio-
logical pH values, whereas we have determined the
pKa value for the amino group mimicking physiologi-
cal conditions with regard to temperature and intracel-
lular ionic osmolarity, i.e., 37°C, 20 mM taurine and
total osmolarity of approximately 300 mOsmol/l. The
taurine titration was monitored by
1HN M Rs p e c t r o -
scopy (Figure 2). The chemical shift ()a n dt h ec o u -
pling of the taurine methylene hydrogens depend on
the ionisation of its amino groups and thus on the pH
in the range 7-10.
From the data of Figure 2, the pKa value for the
taurine amino group was estimated to 9.0 and 8.6 at
25°C and 37°C, respectively. Thus, the pKa value of
taurine at 37°C is within the physiological relevant pH
range. As both values are in good agreement with
values reported for zero ionic strength [26]: pKa=9.06
(25°C), pKa=8.82 (35°C), and pKa=8.71 (40°C), no
major changes of the pKa can be expected in the intra-
cellular environment.
T h ep K av a l u eo ft a u r i n em e a n st h a tm i t o c h o n d r i a l -
localised taurine would contribute significantly to the
mitochondrial pH buffering capacity in the pH range
from 7.5-8.5. A taurine concentration of about 70
µmol/(g protein) in mitochondria [11] represents a
buffering capacity of about 15-40 (µmol H
+)/(g protein)
with the maximum value at pH=pKa. In the classical
study by Mitchell and Moyle, the lowest values for buf-
fering capacity were about 40 (µmol H
+)/(g protein)
observed in the pH range from 7.0-8.5 (compare again
w i t hF i g u r e6a n d7i n[ 2 1 ] ) .O b v i o u s l yt h ev a l u e sa r e
similar, but to draw the correct conclusion the mito-
chondrial pH buffering capacities should be deter-
mined again in a study with controlled concentrations
of taurine.
It should be noted that the concentrations of the
compounds contributing to the mitochondrial pH buf-
fering capacity need to be in balance with the capacity
and regulation of the proton pumping due to the elec-
tron transport chain, ATP-synthase and the proton
leak through uncoupling proteins. If the pH buffering
capacity is too low, the proton pumping could lead to
excessive proton leak or even cause that the matrix
becomes too alkaline with subsequent mitochondrial
damage.
It is reasonable to compare the pH buffering capacity
with the proton pumping turnover in active mitochon-
dria. Values for oxygen consumption can be found to be
about 100-400 (μmol O)/(min∙g protein) [30]. As each
oxygen equivalent pumps 10 protons, a proton turnover
of 1000-4000 (μmol H
+)/(min∙gp r o t e i n )c a nb e
expected. Although a proton buffer capacity of 15-40
(µmol H
+)/(g protein) seems small, it means that the pH
buffering capacity can compensate for transients in oxy-
gen supply of about 0.1-1 s, and thus will provide a
more stable ATP production.
Figure 2 pH dependence of the
1H NMR-spectra of taurine at
25°C and 37°C. pH dependence of the chemical shift () at 25°C
(solid triangles and squares) and 37°C (open triangles and squares)
of the signals. The lines through the data points were obtained
from fits using the pH equation. The estimated pKa values are 9.0
(25°C) and 8.6 (37°C).
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chamber
Stabilising the pH gradient by the presence of a buffer
compound like taurine in the mitochondrial matrix
transforms the matrix into a biochemical reaction cham-
ber with a slightly alkaline pH 8.0-8.5. It is well estab-
lished that several important biochemical processes
occur inside the mitochondrial matrix, e.g., all the reac-
tions in the citric acid cycle, fatty acid oxidation and
some of the reactions in the urea cycle.
In experimental studies of enzymatic reactions, a
number of different buffers are routinely used for con-
trolling pH drifts resulting from the enzyme activity.
Studies on mitochondrial enzymes have traditionally
used non-physiological biological buffers like Tris,
triethanolamine, MOPS or HEPES. This fact can affect
the enzyme activities, pH / activity profiles and pH
optima.
Previously we have studied the pH activity profile of
isocitrate dehydrogenase from the tricarboxylic acid
cycle [1]. The influence of the temperature and the nat-
ure of the buffer on the enzyme activity were studied in
two buffer systems (Tris and taurine). It was found that
that the pH optimum at 37°C is in the pH range 8.0-8.5
for both buffers. This pH optimum coincides with the
expected pH in the mitochondrial matrix and with the
maximal buffering capacity of taurine as buffer (pKa=8.6
at 37°C).
The acyl-CoA dehydrogenases (ACADs) control the
beta-oxidation of fatty acids in animal cells and are
important mitochondrial enzymes involved in fatty acid
degradation. These enzymes exhibit a comparatively low
activity at pH <7 that increases markedly with pH [32].
This dependence reflects apparent pK values of 8-9, also
depending on the specific ACAD (e.g. medium-chain
acyl-CoA dehydrogenase [MCAD], long-chain acyl-CoA
dehydrogenase [LCAD], or short-chain acyl-CoA dehy-
drogenase [SCAD]), on the chain length of the substrate,
and on the composition of the buffer system [32]. It is
i m p o r t a n tt on o t et h a tt h es p ecific activity can increase
by a factor >10 on going from the low pH minimum to
the high pH values [32]. However, reported pH/activity
studies with ACADs used in general Tris buffer at 25°C
and in the presence of a constant concentration of elec-
trolyte (250 mM KCl) [32], conditions that differ sub-
stantially from those in the cell. We have thus
reinvestigated some of these parameters at 37°C in taur-
ine buffer. Figure 3 shows activity/pH profiles for
MCAD, LCAD and SCAD obtained using the ferrice-
nium assay [33]. The activities of these enzymes have
rather low values at pH <7 that increase up to 20-fold
at pH ≥ 9 reflecting apparent pK values of 7.8-8.7.
These apparent pK values compare well with those
reported earlier [32], the minor differences being
attributed to the variation of the ionic strength. In a
general sense, these data demonstrate that fatty acid
metabolism requires sufficient pH buffering of the
matrix, as the beta-oxidation would be impaired if acidi-
fication occurs.
A metabolic regulation argument for the importance
of pH buffering can now be based on the fact that the
acetyl-CoA produced by beta-oxidation is oxidized to
carbon dioxide in the tricarboxylic acid cycle. Produc-
tion of carbon dioxide and an excessive saturation of its
removal processes would induce a pH lowering, and
thus cause lower lipid oxidation. Consequently, the car-
bon dioxide production and subsequent pH control of
the mitochondrial matrix is vital for understanding
metabolic regulation.
Mitochondrial preservation and respiratory measurements
In experiments on preservation of oxidative phosphory-
lation when isolating mitochondria from muscle and
heart tissue, it was found that taurine was the most effi-
cient stabilizer of the compounds studied [34]. An ex-
vivo study on bovine eyes clearly demonstrated that
reperfusion with a taurine solution (1 mM) protected
the mitochondria from swelling and subsequent
Figure 3 pH dependence of the activity of acyl-CoA
dehydrogenases in taurine buffer. Conditions: [taurine] = 47 mM,
[C8-CoA] = 100 µM, [C12-CoA] = 35 µM, [C4-CoA] = 100 µM at 37°C
(substrate concentrations are ≥5￿Km). Enzyme concentration in the
assays was 60 nM. Enzyme activities were estimated using the
ferricenium assay [33] and are normalised for the sake of
comparison. The activities values (turnover) extrapolated to low and
high pH are 560 and 3800 min
-1 for MCAD; 85 and 2400 min
-1 for
LCAD and 160 and 2050 min
-1 for SCAD respectively. The pK values
are derived from the curve fits. The data points are the average of
3-4 individual measurements and the vertical bars indicate the
scatter where appropriate.
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fusion using taurine solutions have shown clear benefi-
cial effects of a taurine pre-treatment [36]. These studies
demonstrate that high extracellular taurine concentra-
tions preserve mitochondrial function and thus prevent
the damaging oxidative burst often observed in reperfu-
sion. A possible explanation to these results is as fol-
lows: The extracellular taurine prevents taurine from
being washed out from from the mitochondria. Conse-
quently, the taurine concentration is kept at an adequate
concentration in the mitochondrial matrix to have cor-
rect function of the proton pumping, so protection is
obtained from the risk that excessive proton pumping
will make the mitochondrial matrix too alkaline causing
mitochondrial degradation.
Besides addition of taurine in media for mitochondrial
preservation, taurine has also been included in media
recommended for respiratory measurements [37]. How-
ever, an artificial buffer like HEPES is also included in
the media. Traditionally respiratory measurements have
been performed in media containing artificial buffers
like HEPES or Tris. In Table 1, we compare data for
oxygen uptake at 30°C in permeabilised rat primary
myotubes using either Tris or Taurine as buffer com-
pounds. The results show no difference between the two
compounds, i.e., taurine can be used as a biological
buffer in cellular systems.
Conclusions and perspectives
The results obtained are all in accordance with the
hypothesis of taurine as mitochondrial matrix buffer.
The obtained pKa value for taurine is ideal for control-
ling the metabolic activity of the ACAD enzymes due to
the obtained very steep activity increase in slightly alka-
line environment. However, obviously additional
research is necessary to fully understand the involve-
ment of taurine in mitochondrial function, e.g. the mito-
chondrial uptake system for taurine need to be
characterised.
It should be noticed that the model presented with
taurine as proton reservoir in the mitochondrial matrix
gives an immediate way to explain some of the mito-
chondrial observations observed in taurine transporter
knockout mice [38]. The decreased exercise capacity can
be ascribed to reduced proton buffering capacity in the
mitochondria. However, the retained cardial function
and almost normal physiological function is to be
expected, as the cardial function can be interpreted as a
steady state condition with regard to proton pumping
a n dt h u sn o td e p e n d i n go np r o t o nb u f f e r i n g .A na l t e r -
native interpretation could be based on developmental
differencies of the mitochondria caused by the taurine
transporter knockout.
Perspectives on mitochondrial dysfunction and diabetes
When ascribing an important role as mitochondrial
matrix pH buffer to taurine, consequently, depletion of
intracellular taurine will be associated directly with
mitochondrial dysfunction. Diabetes and the metabolic
syndrome are the most obvious such examples, as intra-
cellular accumulation of lipids, carbohydrates and poly-
ols are observed, which causes disturbances in the
osmoregulation and implies taurine depletion [31].
However, the hypothesis lacked a causal implication
between taurine deficiency and biochemical function.
Mitochondrial dysfunction caused by insufficient pH
buffering of the matrix could be the missing link.
Recent viewpoints have associated diabetic complica-
tions as well as the impaired insulin secretion and dysli-
pidemia in type 2 diabetes with mitochondrial
dysfunction as unifying hypothesis [39,40]. By applying
the presented mitochondrial matrix-buffering hypoth-
esis, the association from hyperglycemia and lipid accu-
mulation to mitochondrial dysfunction can be provided:
Intracellular accumulation of lipids, carbohydrates and
polyols implies taurine depletion [31], which reduces the
mitochondrial matrix-buffering capacity causing
impaired oxidation, i.e., mitochondrial dysfunction.
Finally, several reports have demonstrated that taurine is
necessary for normal insulin secretion from fetal rat
islets [41]. Taurine could be interpreted as being neces-
sary for mitochondrial development in the islets. Conse-
quently, interpreting taurine as mitochondrial matrix
buffer could improve the understanding of the clinical
alterations observed in diabetes.
Methods
Titration of taurine
Titration of the amino group in taurine was performed
using a solution of 20 mM taurine, 20 mM HCl, 120
mM KCl and subsequent additions of 20 mM KOH.
The NMR spectra were acquired using a Bruker Avance
400 WB operating at 400.13 MHz for
1H and at 310.2 K
(37°C) and at 298.2 K (25°C). A one-dimensional
NOESY (Nuclear Overhauser Spectroscopy) sequence
was used for suppression of the water signal (the first
increment of a 2D NOESY experiment). Spectral
Table 1 Oxygen uptake in permeabilised myotubes either
in Tris or Taurine buffer
Buffer Oxygen uptake, nmol/(min mg protein) RCR
Mean S.E.M. Mean S.E.M.
Tris 20.3 5.9 1.94 0.39
Taurine 19.7 2.6 1.89 0.40
Oxygen uptake was measured with 2 mM malate, 2 mM pyruvate and 2 mM
ADP.
RCR is the fold increase in oxygen uptake by addition of 2 mM ADP to
incubations with 2 mM malate and 2 mM pyruvate.
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performed on all spectra using the gNMR software
(Adept Scientific, Hertfordshire, United Kingdom) to
obtain chemical shift and coupling constant information.
For chemical shift scale reference a small amount of 2,2-
dimethyl-2-silapentane-5-sulphonate, sodium salt was
added. Immediately before each spectrum was acquired,
the sample was thermostated at experiment tempera-
ture, and pH was determined by means of a Radiometer
PHM 64 research pH meter and a Lazar Research Labs
1113R combination pH electrode. As the NMR spectra
typically required 30-60 minutes acquisition time the
electrode was calibrated before each measurement using
appropriate pH standards from Metrohm.
Determination of pH profiles of CAD enzymes
Acyl-CoA dehydrogenases. Activity of ACADs was
assessed with the ferricenium assay [33] at 37°C in a
final volume of 1 ml and following the decrease in
absorbance at 300 nm using a UVIKON 933 spectro-
photometer. Acyl-CoAs were prepared [42] and purified
by preparative HPLC. Acyl-CoA substrate concentra-
tions were determined using ε260 = 15.4 mM
-1cm
-1 in 5
mM potassium phosphate buffer, pH 7.8. MCAD [43],
SCAD and LCAD [44] were obtained as described in
the references. Solutions of ferricenium hexafluoropho-
sphate (Aldrich) were prepared freshly and standardized
spectrophotometrically in 10 mM HCl, using ε617 = 0.41
mM
-1cm
-1. For the assay in 47 mM taurine buffer con-
taining 200 µM ferricenium hexafluorophosphate, the
final concentrations of the substrates C8-CoA (100 µM
for MCAD) or C12-CoA (35 µM for LCAD) were
selected as to be ≥ 5￿Km. The concentrations of the
ACAD enzymes were 60 nM. Data points are the aver-
age of 3-4 determinations. The activities were normal-
ised relative to the observed maximal enzyme activity.
Data analysis, secondary plots and fitting routines
were done with KaleidaGraph (Synergy Software, Read-
ing, Pennsylvania; USA) and SigmaPlot (SPSS Inc., Chi-
cago, Illinois, USA).
Oxygen uptake in permeabilised myotubes
P r i m a r yr a tm y o t u b ec u l t u r e sw e r ep r e p a r e da s
described [45] and permeabilized with 50 µg/ml sapo-
nine for 30 min.
The permeabilized cells were scraped off the culture
dish, and oxygen uptake was measured with a Clark-
type electrode at 30°C. The cell organelles are more
stable at 30°C than 37°C.
Tris buffer for determination of oxygen uptake:
5m MM g C l 2, 6 H2O (Fluka 63072), 60 mM KCl
(AppliChem A1039), 100 mM Mannitol (Mannit no.
63560), 10 mM KH2PO4 (Fluka 60220), 0,5 mM
Na2EDTA, 2 H2O (Fluka 03677), 60 mM Tris-HCl
(Sigma T-3253), 17 mg/ml Phenol red (Sigma P-5530).
pH was adjusted to 7.2 at 30°C with potassium
hydroxide.
Taurine buffer for determination of oxygen uptake:
5m MM g C l 2,6H 2O (Fluka 63072), 60 mM KCl
(AppliChem A1039), 100 mM Mannitol (Mannit art.
5982), 10 mM KH2PO4 (Fluka 60220), 0,5 mM
Na2EDTA, 2 H2O (Fluka 03677), 60 mM Taurine
(Sigma T-0625), 17 mg/ml Phenol red (Sigma P-5530).
pH were adjusted to 7.2 at 30°C with potassium
hydroxide.
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